Related Experiment Video
Updated: Aug 29, 2026

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay
Published on: January 26, 2019
The progression of maternal RSV antibodies in the offspring
M Hacimustafaoglu1, S Celebi, E Aynaci
1Uludag University Medical Faculty, Department of Pediatrics and Pediatric Infectious Diseases, Görükle, Bursa, Turkey. mkemal@uludag.edu.tr
Insights
Maternal anti-RSV IgG antibody levels in newborns decline rapidly in the first six months. Low antibody concentrations (<20 RU/ml) correlated with respiratory syncytial virus (RSV) infection, suggesting a protective threshold.
Area of Science:
- Immunology
- Pediatrics
- Virology
Background:
- Maternal antibodies are crucial for infant immunity.
- Respiratory Syncytial Virus (RSV) is a major cause of infant respiratory illness.
- Understanding antibody decay is key for assessing infant vulnerability.
Purpose of the Study:
- To track maternal anti-RSV IgG antibody concentrations in newborns over six months.
- To determine the correlation between antibody levels and RSV infection acquisition.
- To identify a potential protective antibody threshold against RSV.
Main Methods:
- Longitudinal study of 49 healthy newborns.
- Measurement of maternal anti-RSV IgG antibody concentrations.
- Monitoring for RSV infection and clinical presentation.
Main Results:
- All infants had maternal anti-RSV IgG at birth; positivity decreased to 2% by 6 months.
- RSV infection occurred in 8% of infants between 3-6 months.
- Clinical RSV disease was associated with antibody concentrations below 20 RU/ml.
Conclusions:
- Maternal anti-RSV IgG wanes significantly in the first six months of life.
- A threshold of <20 RU/ml may indicate insufficient protection against RSV.
- Further research is needed to confirm this protective threshold.
Abstract:
The concentrations of maternal anti-RSV IgG antibodies were followed in 49 healthy newborns over the first six months of life. At birth, 41 mothers (83%) tested positive for anti-RSV IgG and all of their babies carried maternal anti-RSV IgG. Anti-RSV IgG positivity dropped to 73% at 1 month, 6% at 3 months, and 2% at 6 months. Between 3 and 6 months, 8% did acquire RSV infection, half of them as acute bronchiolitis and half as non-specific respiratory infection. All of the patients who acquired clinical RSV disease had an antibody concentration of <20 RU/ml which may be the cut off value for protection.
More Related Videos
Related Concept Videos
Respiratory Syncytial Virus Disease
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Cytomegalovirus Disease
Rabies

